Thursday, 27 July 2023

BIIB Earnings: A snapshot of Biogen’s Q2 2023 financial results

by Rose White

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the second quarter of 2023.

BIIB Earnings: A snapshot of Biogen’s Q2 2023 financial results

BIIB Earnings: A snapshot of Biogen’s Q2 2023 financial results

Total revenue declined 5% year-over-year to $2.46 billion. For the full year of 2023, the company expects revenues to decline in the mid-single digit percentage and projects adjusted earnings per share in the range of $15.00 to 16.00.

Net income attributable to Biogen Inc. was $591.6 million or $4.07 per share in Q2, compared to $1.06 billion or $7.24 per share last year. Adjusted earnings declined 23% to $4.02 per share.

Prior Performance

  • Biogen-Q4-2022-Earnings-Infographic
  • Biogen Q3 2022 earnings infographic
  • Biogen Q2 2022 Earnings Infographic

The post BIIB Earnings: A snapshot of Biogen’s Q2 2023 financial results first appeared on AlphaStreet.

signup-banner

Loading